Off-label use of cardiovascular drugs as an indicator of therapeutic need in paediatrics

Eur J Hosp Pharm. 2024 Feb 22;31(2):179. doi: 10.1136/ejhpharm-2022-003635.
No abstract available

Keywords: CARDIOLOGY; ETHICS, CLINICAL; Ethics, pharmacy; PEDIATRICS; Quality of Health Care; Safety.

Publication types

  • Letter

MeSH terms

  • Cardiovascular Agents* / adverse effects
  • Child
  • Drug Labeling
  • Humans
  • Off-Label Use*

Substances

  • Cardiovascular Agents